Ogo, Takeshi <br/><br/>
Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.  [electronic resource] 

 -  American journal of respiratory cell and molecular biology  Jun 2013 
 - 733-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-4989 
<br/><br/><label>Standard No.: </label>10.1165/rcmb.2012-0049OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Morphogenetic Protein Receptors, Type II--genetics<br/>Cell Proliferation--drug effects<br/>Codon, Nonsense<br/>Epoprostenol--analogs & derivatives<br/>Familial Primary Pulmonary Hypertension<br/>HEK293 Cells<br/>Humans<br/>Hypertension, Pulmonary--metabolism<br/>Lung--drug effects<br/>MAP Kinase Signaling System<br/>Male<br/>Mice<br/>Monocrotaline--pharmacology<br/>Myocytes, Smooth Muscle--drug effects<br/>Phosphorylation<br/>Protein Serine-Threonine Kinases--genetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Transforming Growth Factor-beta Type II<br/>Receptors, Transforming Growth Factor beta--genetics<br/>Smad3 Protein--genetics<br/>Transforming Growth Factor beta1--antagonists & inhibitors